Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Is FIB-4 the right tool for screening for liver fibrosis?
Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;
10.1016/j.aohep.2025.102176
Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease
Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro;
10.1016/j.aohep.2024.101541
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589